Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Cancer Research and Treatment. 2017;49(4):1001-1011 
Results of a clinical multicentric randomized phase II study of non-small cell lung cancer treated with vinorelbine-cisplatin versus vinorelbine alone
Lung Cancer. 1995;12(3):307
Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial
Yearbook of Oncology. 2012;2012:187-188
Randomized study of NavelbineR and cisplatin versus vindesine and cisplatin versus NavelbineR alone in 612 patients with advanced non-small cell lung cancer (NSCLC)
Lung Cancer. 1996;16(1):120
Afatinib
Reactions Weekly. 2017;1675(1):19-19
Afatinib treatment in advanced non-small cell lung cancer
Lung Cancer: Targets and Therapy. 2011;47
Afatinib
Reactions Weekly. 2017;1656(1):21-21
Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer
Lung Cancer. 1993;8(5-6):348
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: A hoosier oncology group trial
Lung Cancer. 1995;13(2):221-222
Randomized phase II trial comparing trastuzumab plus weekly docetaxel versus trastuzumab plus weekly paclitaxel in previously untreated advanced non-small cell lung cancer (NSCLC)
Lung Cancer. 2000;29(1):57